HUTCHMED (China) (HCM) Cash & Current Investments (2014 - 2026)
HUTCHMED (China) (HCM) posted quarterly Cash & Current Investments of $1.4 billion for Q2 2026, up 0.75% year-over-year from $1.4 billion in Q2 2025, and up 682.04% quarter-over-quarter from $175.8 million in Q4 2025.
HUTCHMED (China) (HCM) Cash & Current Investments (2014 - 2026) Analysis & Trends
HUTCHMED (China) (HCM) has reported Cash & Current Investments for 13 consecutive years, with $1.4 billion the latest figure, recorded in Q2 2026.
- In Q2 2026, Cash & Current Investments rose 0.75% year-over-year to $1.4 billion; the TTM figure through Jun 2026 stood at $1.4 billion (up 0.75% YoY), while the FY2025 annual figure was $175.8 million, up 64.06% from the prior year.
- Cash & Current Investments improved to $1.4 billion in Q2 2026 per HCM's latest filing, from $175.8 million in the prior quarter.
- Across five years, Cash & Current Investments topped out at $1.4 billion in Q2 2026 and bottomed at $113433.7 in Q4 2023.
- Historically, Cash & Current Investments has averaged $620.9 million across 5 years, with a median of $802.5 million in 2024.
- Annual changes were most pronounced in 2023 — Cash & Current Investments tumbled 99.86% — and 2024, when it jumped 94712.72%.
- HUTCHMED (China)'s Cash & Current Investments stood at $80.7 million in 2022, then plunged by 99.86% to $113433.7 in 2023, then surged by 94712.72% to $107.5 million in 2024, then soared by 63.46% to $175.8 million in 2025, then jumped by 682.04% to $1.4 billion in 2026.
- Business Quant data shows HCM's Cash & Current Investments at $1.4 billion in Q2 2026, $175.8 million in Q4 2025, and $1.4 billion in Q2 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash & Current Investments (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 44.51 Bn | 43.55 Bn | - | 963.33 Mn |
| 2 | Teva Pharmaceutical Industries | 43.52 Bn | 39.86 Bn | 2.15 Bn | 3.66 Bn |
| 3 | Zoetis | 32.43 Bn | 30.75 Bn | 1.05 Bn | 1.68 Bn |
| 4 | Takeda Pharmaceutical | 28.63 Bn | 22.83 Bn | 5.10 Bn | 5.80 Bn |
| 5 | United Therapeutics | 21.87 Bn | 19.21 Bn | 683.80 Mn | 2.66 Bn |
| 6 | Viatris | 18.98 Bn | 18.09 Bn | 1.46 Bn | 886.50 Mn |
| 7 | Neurocrine Biosciences | 15.43 Bn | 15.04 Bn | 935.80 Mn | 389.80 Mn |
| 8 | Elanco Animal Health | 12.02 Bn | 11.49 Bn | 798.00 Mn | 530.00 Mn |
| 9 | Dr Reddys Laboratories | 10.14 Bn | 9.98 Bn | - | 164.00 Mn |
| 10 | HUTCHMED (China) | 2.19 Bn | 2.19 Bn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 1.37 Bn |
| Dec 31, 2025 | 175.80 Mn |
| Jun 30, 2025 | 1.36 Bn |
| Dec 31, 2024 | 107.55 Mn |
| Jun 30, 2024 | 802.45 Mn |
| Dec 31, 2023 | 113,433.74 |
| Jun 30, 2023 | 856.17 Mn |
| Dec 31, 2022 | 80.67 Mn |
| Jun 30, 2022 | 826.20 Mn |
| Dec 31, 2021 | 129.88 Mn |
| Jun 30, 2021 | 950.45 Mn |
| Mar 31, 2021 | 396.07 Mn |
| Dec 31, 2020 | 435.18 Mn |
| Jun 30, 2020 | 281.01 Mn |
| Dec 31, 2019 | 217.17 Mn |
| Sep 30, 2019 | 201.58 Mn |
| Jun 30, 2019 | 237.29 Mn |
| Mar 31, 2019 | 271.86 Mn |
| Dec 31, 2018 | 300.95 Mn |
| Jun 30, 2018 | 322.49 Mn |